Anavex Life Sciences Corp (AVXL)

[nidan7500]

NOT ANY MORE:thx Jimmy:

Conclusion: Sig-1R agonists have been used in the treatment of different neurodegenerative diseases, e.g. Alzheimer’s and Parkinson’s diseases (AD and PD) and amyotrophic lateral sclerosis. Utilization of Sig-1R agents early in AD and similar other diseases has remained an overlooked therapeutic opportunity.

I think we all understand that decisions must be made in every development cycle. These are typically made w/consideration for time used, resources available, money, equipment..all the usual. Thankfully (looks like) not this time for A2-73 and others. We got it.

http://www.eurekaselect.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#r43